Showing 12,801 - 12,820 results of 107,116 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (a decrease)) ))', query time: 1.96s Refine Results
  1. 12801
  2. 12802
  3. 12803

    Treatment adoption and diffusion pattern. by Frédéric Galacteros (11105678)

    Published 2023
    “…In clinical studies, voxelotor has been shown to increase hemoglobin (Hb) and decrease hemolytic markers in patients with SCD. The objective of this study was to estimate the impact of voxelotor on the burden of SCD in France using a modeling approach, accounting for its anticipated adoption and diffusion over the next 5 years. …”
  4. 12804
  5. 12805

    The <i>TgCRT</i>-deficient parasites displayed a swollen vacuole and a disrupted endolysosomal system. by L. Brock Thornton (6808385)

    Published 2019
    “…Scale bar = 5 μm. (B) The swollen subcellular structure indicated by the arrow was also observed in pulse-invaded <i>Δcrt</i> parasites and colocalized with a major luminal peptidase of the VAC, cathepsin L-like protease (TgCPL). …”
  6. 12806

    Cell wall lysis activity of P5<sup>wt</sup> and P5<sup>V207F</sup>. by Moshe Dessau (116156)

    Published 2012
    “…<p>A) To measure the cell lysis activities of P5<sup>wt</sup> and P5<sup>V207F</sup> the turbidity of chloroform-treated <i>E. coli</i> was measured as absorbance at 450 nm at 25°C. …”
  7. 12807
  8. 12808
  9. 12809
  10. 12810
  11. 12811

    Supplementary Material for: Structural and functional effects of C5aR1 antagonism in a rat model of neonatal hypoxic-ischemic encephalopathy by Saadat A. (18613231)

    Published 2024
    “…Reasoning C5aR1 antagonism can decrease excessive neuroinflammation and thereby improve neurological and functional outcomes, we tested this hypothesis in a rat model of HIE with PMX205, a small molecule that inhibits C5a-C5aR1 interaction. …”
  12. 12812
  13. 12813
  14. 12814

    Comparison of potential energy minimization curves of hypothetical monomer chains from non-capsid and capsid dimers. by Weimin Wu (505435)

    Published 2020
    “…<p>Compared are apo 3KXS (A) and liganded 5E0I (B) non-capsid chains with the apo T = 4 1QGT capsid chains (C). …”
  15. 12815
  16. 12816
  17. 12817

    PowerPoint Slides for: Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial by Foster R. (3291450)

    Published 2016
    “…Cognitive impairment was defined as a MoCA score of ≤24. We determined the prevalence and risk factors for cognitive impairment in patients with CKD stages G4-G5, not on dialysis. …”
  18. 12818
  19. 12819
  20. 12820